| |
 |
Program Objectives
Upon completion of this program, pharmacists should be able to:
- Define the scope and clinical risk factors associated with menopause.
- Examine the economic implications of hormone replacement therapy in menopause and post-menopausal women.
- Review current medications used to manage menopausal vasomotor symptoms and other related symptoms.
- Discuss pharmacoeconomic studies that have analyzed the use of hormone replacement therapy to prevent and/or treat menopause-induced vasomotor symptoms.
- Identify new methods to manage menopausal vasomotor symptoms.
Pharmacy Continuing Education Credits
Rutgers, The State University of New Jersey, is approved by the American Council on Pharmaceutical Education (ACPE) as a provider of continuing education and complies with the Criteria for Quality for continuing pharmaceutical education programming. "This program is approved for 2.50 contact
hours of continuing pharmaceutical education credit (0.25 CEUs) for participants who submit a program evaluation form at the conclusion of the program.
The Universal Program Number is 038-999-00-029-H01.
The target audience for this educational program are managed care pharmacists.
Provided through an unrestricted educational grant from 
|
